We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

88 hedge funds and large institutions have $173M invested in Vaxart in 2020 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 8

222% more capital invested

Capital invested by funds: $53.9M → $173M (+$119M)

120% more funds holding

Funds holding: 40 → 88 (+48)

100% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 8

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

16.57% less ownership

Funds ownership: 42.99% → 26.42% (-17%)

Holders
88
Holders Change
+48
Holders Change %
+120%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
56
Increased
16
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$8.9M
2
BlackRock
BlackRock
New York
+$8.18M
3
VA
VR Adviser
New York
+$7.94M
4
BBA
Baker Bros. Advisors
New York
+$4.71M
5
Millennium Management
Millennium Management
New York
+$2.47M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$72M
2
Renaissance Technologies
Renaissance Technologies
New York
-$4.47M
3
HSA
Hussman Strategic Advisors
Maryland
-$862K
4
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
-$119K
5
HIS
Harvest Investment Services
Illinois
-$88K

VXRT Hedge Fund Activity: Q2 2020 in Review

88 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2020, worth a combined $173M — up 222% from $53.9M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new VXRT positions and 8 closed out — a net gain of 48 holders — while 16 added to existing stakes and 8 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $8.9M. The largest seller was Armistice Capital, cutting an estimated $72M.

  • 88 institutional investors held Vaxart (VXRT) as of Q2 2020, up from 40 in Q1 2020.
  • Funds reported $173M of Vaxart stock for Q2 2020, up 222% quarter-over-quarter.
  • 56 funds opened new Vaxart positions in Q2 2020 and 8 closed out, a net change of +48 holders.
  • The largest Vaxart buyer in Q2 2020 was Citadel Advisors, an estimated $8.9M added.
  • The largest Vaxart seller in Q2 2020 was Armistice Capital, an estimated $72M sold.

Based on aggregated 13F filings for Q2 2020.